Roche Holding Ltd. (VTX:ROG) has earned an “AA-” credit rating from Morningstar. The research firm’s “AA-” rating indicates that the company is a very-low default risk. They also gave their stock a four star rating.

A number of other equities research analysts also recently weighed in on ROG. JPMorgan Chase & Co. reiterated a “buy” rating on shares of Roche Holding in a report on Monday, January 25th. Morgan Stanley reiterated a “buy” rating on shares of Roche Holding in a report on Friday, November 6th. Finally, Goldman Sachs reiterated a “buy” rating on shares of Roche Holding in a report on Friday, November 6th.

Roche Holding (VTX:ROG) opened at 263.90 on Monday. The firm has a market cap of CHK 224.83 billion and a price-to-earnings ratio of 26.03. The company’s 50-day moving average price is CHK 267.29 and its 200-day moving average price is CHK 266.96. Roche Holding has a 52-week low of CHK 241.10 and a 52-week high of CHK 283.90.

Roche Holding AG (VTX:ROG) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Company’s Pharmaceuticals Division comprises the two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. Its activities are structured into six geographical segments: North America; Asia-Pacific; Western Europe; Latin America; Europe, the Middle East and Africa (EMEA), and Japan. The Company focuses on a select group of disease areas, including oncology, hematology, neuroscience, immunology, inflammation, ophthalmology, infectious and rare diseases. Its key pharmaceutical products include Avastin, Herceptin, Perjeta, Kadcyla, MabThera/Rituxan, Lucentis, Actemra/RoActemra, Zelboraf and Gazyva/Gazyvaro.

To view more credit ratings from Morningstar, visit www.jdoqocy.comclick-7674909-10651170.

Frustrated with your broker? Are you tired of paying high fees? Do you feel like you are getting ripped off by your stock broker? It's time for a change. Find out which brokerage is best for your personal trading style at the InvestorPlace Broker Center. Compare brokers at a glance in the InvestorPlace Broker Center (Click Here).

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.